Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Nucleoside diphosphate kinase B pseudogene" is a non-coding DNA sequence in the human genome that shares high sequence similarity with the NME2 gene, which encodes the functional Nucleoside diphosphate kinase B enzyme. Unlike its protein-coding counterpart, this pseudogene does not produce a functional protein product and has no direct biological or clinical role. While its functional gene, NME2, plays a key role in cellular nucleotide homeostasis and is involved in several cellular pathways, the pseudogene itself is not considered a molecular target for therapeutics or diagnostics[1]. This entry is flagged as incorrect as a therapeutic target because pseudogenes, by definition, do not produce active proteins and thus are not directly targeted by drugs or involved in disease mechanisms in the manner that protein-coding genes are[1]. The correct functional target in this family is Nucleoside diphosphate kinase B (NME2).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleoside diphosphate kinase B pseudogene.